乌干达北部地方性伯基特淋巴瘤与HLA系统变异的关联
本研究在乌干达北部纳入200例0-15岁地方性伯基特淋巴瘤(eBL)病例和400名对照,采用高分辨率HLA测序分型,分析HLA等位基因与eBL风险的关联。结果显示HLA-A*02、HLA-B*41、HLA-B*58及HLA-DPB1纯合性与较低eBL风险相关,而HLA-DQA1纯合性与较高风险相关,提示HLA变异可能与eBL风险相关。
要点
- HLA-A*02、HLA-B*41、HLA-B*58等位基因与eBL风险降低相关。
- HLA-DPB1纯合性与eBL风险降低相关,HLA-DQA1纯合性与风险升高相关。
- 采用高分辨率HLA测序分型,较既往血清学方法更准确。
核心结论
- HLA系统变异可能与地方性伯基特淋巴瘤风险相关。
研究设计与样本
- 病例对照研究,纳入200例0-15岁eBL病例和400名对照,来自乌干达北部,采用高分辨率HLA测序分型。
临床怎么用
- HLA分型结果可能为eBL风险分层提供参考,但尚需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Endemic Burkitt lymphoma (eBL) is an aggressive childhood B-cell lymphoma associated with Plasmodium falciparum (Pf) malaria and Epstein-Barr virus (EBV) infections. Variation in the Human Leukocyte Antigen (HLA) system is suspected to play a role, but assessments using less accurate serology-based HLA typing techniques in small studies yielded conflicting results. We studied 200 eBL cases and 400 controls aged 0-15 years enrolled in northern Uganda and typed by accurate high-resolution HLA sequencing methods. HLA results were analyzed at one- or two-field resolution. Odds ratios and 95% confidence intervals (aOR, 95% CI) for eBL risk associated with common HLA alleles versus alleles that were rare (<1%) or differed by <2% between the cases and controls as the reference category, were estimated using multiple logistic regression adjusting for age, sex, microgeography, region, malaria positivity and treatment history, and genetic variants associated with eBL. Compared to the controls, eBL cases had a lower frequency of HLA-A*02 (aOR = 0·59, 95% CI 0·38-0·91), HLA-B*41 (aOR = 0·36, 95% CI 0·13-1·00), and HLA-B*58 alleles (aOR = 0·59, 95% CI 0·36-0·97). eBL cases had a lower frequency of HLA-DPB1 homozygosity (aOR = 0·57, 95% CI 0·40-0·82) but a higher frequency of HLA-DQA1 homozygosity (aOR = 2·19, 95% CI 1·42-3·37). Our results suggest that variation in HLA may be associated with eBL risk.
引用
- Kirimunda S, Verboom M, Otim I, et al. Variation in the Human Leukocyte Antigen system and risk for endemic Burkitt lymphoma in northern Uganda. Br J Haematol. 2020. PMID: 32072624. doi:10.1111/bjh.16398
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。